EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Molecular mechanisms underlying adverse effects of dexamethasone and betamethasone in the developing cardiovascular system

Tessa A C Garrud iD, Noor E W D Teulings iD, Youguo Niu iD, Katie L Skeffington iD, Christian Beck, Nozomi Itani, Fiona G Conlon, Kimberley J Botting, Lisa M Nicholas iD, Wen Tong, Jan B Derks, Susan E Ozanne iD und 1 weitere

The FASEB Journal · 2023

DOI: 10.1096/fj.202200676rr ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2023. Verfasst von Tessa A C Garrud und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, UK. Hauptthemen laut MEDLINE: Betamethasone, Glucocorticoids. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: British Heart Foundation, Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antenatal glucocorticoids accelerate fetal lung maturation and reduce mortality in preterm babies but can trigger adverse effects on the cardiovascular system. The mechanisms underlying off‐target effects of the synthetic glucocorticoids mostly used, Dexamethasone (Dex) and Betamethasone (Beta), are unknown. We investigated effects of Dex and Beta on cardiovascular structure and function, and underlying molecular mechanism using the chicken embryo, an established model system to isolate effects of therapy on the developing heart and vasculature, independent of effects on the mother or placenta. Fertilized eggs were treated with Dex (0.1 mg kg −1 ), Beta (0.1 mg kg −1 ), or water vehicle (Control) on embryonic day 14 (E14, term = 21 days). At E19, biometry, cardiovascular function, stereological, and molecular analyses were determined. Both glucocorticoids promoted growth restriction, with Beta being more severe. Beta compared with Dex induced greater cardiac diastolic dysfunction and also impaired systolic function. While Dex triggered cardiomyocyte hypertrophy, Beta promoted a decrease in cardiomyocyte number. Molecular changes of Dex on the developing heart included oxidative stress, activation of p38, and cleaved caspase 3. In contrast, impaired GR downregulation, activation of p53, p16, and MKK3 coupled with CDK2 transcriptional repression linked the effects of Beta on cardiomyocyte senescence. Beta but not Dex impaired NO‐dependent relaxation of peripheral resistance arteries. Beta diminished contractile responses to potassium and phenylephrine, but Dex enhanced peripheral constrictor reactivity to endothelin‐1. We conclude that Dex and Beta have direct differential detrimental effects on the developing cardiovascular system.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BetamethasoneGlucocorticoidsChick EmbryoFemalePregnancyAnimalsHeartArteriesDexamethasone

Substanzen

BetamethasoneGlucocorticoidsDexamethasone

Autor:innen und Institutionen

  • Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, UK.
  • Institute of Metabolic Science-Metabolic Research Laboratories, MRC Metabolic Diseases Unit, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.
  • Department of Perinatal Medicine, University Medical Centre, Utrecht, Netherlands.
  • BHF Cardiovascular Centre for Research Excellence, University of Cambridge, Cambridge, UK.
  • Strategic Research Initiative in Reproduction, University of Cambridge, Cambridge, UK.
  • Centre for Trophoblast Research, University of Cambridge, Cambridge, UK.

ORCID-Profile: Tessa A C Garrud, Noor E W D Teulings, Youguo Niu, Katie L Skeffington, Lisa M Nicholas, Susan E Ozanne, Dino A Giussani

Förderung

  • British Heart Foundation
  • Medical Research Council

Zitieren

APA

Garrud, T. A. C., Teulings, N. E. W. D., Niu, Y., Skeffington, K. L., Beck, C., Itani, N., Conlon, F. G., Botting, K. J., Nicholas, L. M., Tong, W., Derks, J. B., Ozanne, S. E., & Giussani, D. A. (2023). Molecular mechanisms underlying adverse effects of dexamethasone and betamethasone in the developing cardiovascular system. The FASEB Journal. https://doi.org/10.1096/fj.202200676rr

Vancouver

Garrud TAC, Teulings NEWD, Niu Y, Skeffington KL, Beck C, Itani N, et al. Molecular mechanisms underlying adverse effects of dexamethasone and betamethasone in the developing cardiovascular system. The FASEB Journal. 2023. doi:10.1096/fj.202200676rr

BibTeX
@article{Garrud2023,
  author = {Garrud, Tessa A C and Teulings, Noor E W D and Niu, Youguo and Skeffington, Katie L and Beck, Christian and Itani, Nozomi and Conlon, Fiona G and Botting, Kimberley J and Nicholas, Lisa M and Tong, Wen and Derks, Jan B and Ozanne, Susan E and Giussani, Dino A},
  title = {Molecular mechanisms underlying adverse effects of dexamethasone and betamethasone in the developing cardiovascular system},
  journal = {The FASEB Journal},
  year = {2023},
  doi = {10.1096/fj.202200676rr}
}
Kostenlos starten →